Upcoming event
EAU UROonco: A meeting steered by the EAU Section of Oncological Urology
Back

Tag: EAU21

EAU21: Virtual meeting but crucial findings!

EAU21: remembered for the incredible high level of scientific information provided

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

DANUBE post-hoc analysis: Outcomes for durvalumab with or without tremelimumab by cisplatin eligibility and PD-L1 biomarker status in metastatic urothelial carcinoma

Expert summary

Expert summary

Society of Urologic Oncology (SUO) lecture The VHL kidney cancer gene: Discovery, oxygen sensing and therapy

Expert summary

PURE-02: An open-label, single-arm, feasibility study of neoadjuvant pembrolizumab before Radical Nephroureterectomy (RNU) in patients with high-risk, Upper-Tract Urothelial Carcinoma (UTUC)

Safety evaluation of sequential Mitomycin and Bacillus Calmette-Guérin treatment versus Bacillus Calmette-Guérin monotherapy in patients with high risk non-muscle invasive bladder cancer: MITOBCG study (EUDRACT Number 2017-004540-37) preliminary results